Clorazepate dipotassium is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. It has depressant effects on the central nervous system. The primary metabolite, nordiazepam, quickly appears in the blood stream. The serum half-life is about 2 days.
Standard fertility, reproduction, and teratology studies were conducted in rats and rabbits. Oral doses in rats up to 150 mg/kg and in rabbits up to 15 mg/kg produced no abnormalities in the fetuses. Clorazepate dipotassium did not alter the fertility indices or reproductive capacity of adult animals. As expected, the sedative effect of high doses interfered with care of the young by their mothers (see Usage in Pregnancy).
The 7.5 mg tablets are peach round, scored tablets debossed with M above the score and 40 below the score on one side of the tablet and blank on the other side. They are available as follows:
blister of 30 tablets
Protect from moisture. Keep bottle tightly closed. Store between 20° to 25°C (68° to 70°F) [see USP Controlled Room temperature]. Dispense in a USP tight, light-resistant container.
Mylan Pharmaceuticals Inc.
Morgantown, WV 26505
Contract Pharmacy Services-PA
125 Titus Ave Suite 200
Warrington, PA 18976 USA
7.5 mg Tablets
| CLORAZEPATE DIPOTASSIUM |
clorazepate dipotassium tablet
|Labeler — Contract Pharmacy Services-PA (945429777)|
Revised: 12/2010 Contract Pharmacy Services-PA